Arca
Skip to content

SRD5A2: 3-oxo-5-alpha-steroid 4-dehydrogenase 2

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Catalyzes the irreversible stereospecific reduction of the delta 4,5 bond (double bond between carbons 4 and 5) of various 3-oxo steroids (3-keto steroids) producing their 5alpha dihydro-3-oxo forms.

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DrugUS approvalMechanismActionWarnings
FinasterideApprovedSteroid 5-alpha-reductase 2 inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
0.83
Androgenetic alopecia
0.70
Benign prostatic hyperplasia
0.63
Prostate carcinoma
0.61
Prostate neoplasm
0.47
Hypotrichosis
0.46
Micropenis
0.42
Neoplasm
0.39
Skin aging
0.34

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
SRD5A2

Drugs and mechanisms are from ChEMBL CHEMBL1856 (CC BY-SA 3.0). Gene name, function (UniProt P31213, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.